HARBIN, China, July 5 /Xinhua-PRNewswire-FirstCall/ -- China Kangtai Cactus Biotech, Inc. (OTC Bulletin Board: CKGT), a vertically integrated grower, developer, manufacturer and marketer of a variety of cactus-based consumer products, announced today that the Company has launched five new products to better meet consumers' increasing demand. This launch follows market and product positioning analyses and successful pre-launch testing. The five products are:
1. Cactus Ruddy Soft Capsules
In addition to cactus, this product contains fortified vitamin compounds,
calcium enrichment, and deer extracts. This product improves vitality and
blood state, strengthens heart and kidney functions, and fights fatigue,
shivering, irregular heartbeat, sweating, and absent mindedness.
Additionally, this product promotes a younger and healthier appearance.
Target market: middle-aged and elderly population.
2. Cactus Rattle Stick Flower Capsules
This product contains rattle stick flowers, deer reproductive organs and
wolfberry fruits. It boosts the immune systems, internal systems and
organs. Additionally, this product combats many male dysfunctions.
Target market: male population.
3. Cactus Water Honey Pills
These 6mm pills are made entirely of cacti, formulated through a process
of dehydration and micro grinding. This product mainly functions as an
immune system strengthener and also supplements the treatment of cancer,
diabetes, and heart and brain blood vessel related problems. Target
market: general public.
4. Cactus Energy and Hydration Drinks
These cactus-based juices contain enriched multi-vitamins and minerals.
They help to restore energy and combat fatigue. Target market: general
public.
5. Cactus Vinegar Drinks
Vinegar is known to aid in rapid weight loss, cleanse internal organs, and
improve skin conditions. Fresh cactus juice, together with vinegar,
honey, rock sugar, and vitamin C, has been shown to enhance the appetite
in children, improve digestion and metabolism in young and middle-aged
people, promote radiant skin in women, and reduce blood alkaline levels in
the elderly population, thus preventing cholesterol and high blood
pressure problems. Target market: general public.
The benefits of the above-mentioned products are based on the theory of traditional Chinese medicine and consistent results accumulated over thousands of years. According to The Grand Dictionary of Chinese Medicine and the Compendium of Materia Medica, as well as many certified tests and analyses carried out by the Department of Agriculture and the Institute for Nutrition and Food Safety of the Center of Disease Prevention and Control of China, cacti contain over 18 kinds of amino acid, carbohydrates, chief meal fibrin, carotene, vitamin C, vitamin E, vitamin K1, vitamin B1, vitamin B2, vitamin B6, vitamin B12, smoke acid, folacin, calcium, phosphorus, iron, potassium, sodium, magnesium, manganese, copper, zinc, iodine, and selenium. Various cactus products have been shown to provide health benefits and have been used to treat a variety of health issues including, diabetes, adiposity, constipation, cholesterol, high blood pressure, low immunity, and various skin disorders.
China Kangtai owns nearly 400 acres of farmland and grows three species of Mexican cacti and some of the Company's own cloned species. The Company owns an R & D institute that has successfully produced 30 product patents, 15 of which have already been approved. It currently produces and sells four cactus-based product categories: nutraceuticals, which are health and wellness dietary supplements; beverages, including juice, teas, beer, wine, and spirits; packaged foods, such as noodles, biscuits and pickles; and raw and intermediate cactus materials. There are about 32 existing products under these four categories.
Besides adding new products to the above four categories, the Company is planning to launch two more product categories in 2007 and 2008. They are cactus-based personal care products and cactus-based animal feed and nutrition.
Jinjiang Wang, Chief Executive Officer of China Kangtai Cactus Biotech commented, "Cactus based products are well received by the market in China and show huge growth potentials. China Kangtai will continue to develop more new products to meet the demand of the consumers, and at the same time penetrate the markets with existing products."
Wang concluded, "Our Company remains focused on quality and functionality of our products that deliver various health benefits to the consumers. These new products will contribute positively to Company's 2007 performance and beyond, and accelerate its revenue and profit growth. With 15 product patents and 15 pending approval, China Kangtai is the dominant player in the cactus-based consumer product sector."
About China Kangtai Cactus Bio-Tech Inc.
China Kangtai Cactus Bio-Tech, Inc. is market-leading cactus grower and producer of cactus-related products with over 387 acres of plants and an active R&D group that holds 15 product patents and is seeking another 15 in a variety of product categories. China Kangtai's high-quality products are sold throughout China in supermarkets, food stores, hotels and restaurants through a growing distribution network that has currently covered 22 provinces and 3 municipalities.
Cautionary Statement Regarding Forward Looking Information
This press release contains forward-looking information about China Kangtai Cactus Bio-tech that is intended to be covered by the safe harbor for forward-looking statements provided by the Private Securities Litigation Reform Act of 1995. Forward-looking statements are statements that are not historical facts. These statements can be identified by the use of forward-looking terminology such as "believe," "expect," "may," "will," "should," "project," "plan," "seek," "intend," or "anticipate" or the negative thereof or comparable terminology, and include discussions of strategy, and statements about industry trends and China Kangtai Cactus Bio-tech future performance, operations and products.
This forward-looking information should be considered only in connection with "Risk Factors" in China Kangtai Cactus Bio-tech's annual report on Form 10KSB filed with the SEC on April 2, 2007, and its other current and periodic reports filed with the SEC. China Kangtai Cactus Bio-tech assumes no obligations to update any forward-looking statements or information set forth in this press release.
Disclaimer
The nutraceutical and some of the beverage products that China Kangtai produces and markets are dietary supplements rather than pharmaceuticals. They are not sold in the US, and any claims regarding the health benefits associated with use of the products have not been invested or approved by the US Food and Drug Administration.
For more information, please contact:
At the Company:
Ren Hu
Vice President
China Kangtai Cactus Bio-tech, Inc.
Tel: +1-201-887-0415
Email: Arenhu@gmail.com
Investor Relations:
RedChip Companies, Inc.
Jon Cunningham
Tel: +1-800-RedChip x107
Email: Jon@RedChip.com or Info@RedChip.com
Web: http://www.RedChip.com
